KHATTAR JACK A. (President, CEO) sold 3.5% of their position (35K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.76M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/16/2026ACC: 0001539937-26-000008
DirectorOfficer· President, CEO
Since Feb 2026
-35K
Net shares
Net seller
$1.76M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
12.50K acquired · 47.50K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
1.0%
3/13/2026
1.23M→1.24M
Common Stock
Indirect
Shares
−12.50K
Price / share
—
Trade value
—
% of position
1.2%
3/13/2026
1.01M→993.10K
Common Stock
Indirect
Shares
−24.14K
Price / share
$50.09
Trade value
$1.21M
% of position
2.4%
3/13/2026
993.10K→968.96K
Common Stock
Indirect
Shares
−10.74K
Price / share
$51.00
Trade value
$547.84K
% of position
1.1%
3/13/2026
968.96K→958.22K
Common Stock
Indirect
Shares
−120.00
Price / share
$51.75
Trade value
$6.21K
% of position
0.0%
3/13/2026
958.22K→958.10K
Total
Net shares
−35K
Net value
-$1.76M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | J · J | +12.50K | — | — | 1.0% | 1.23M | 1.24M |
| Common Stock Indirect | 3/13/2026 | J · J | −12.50K | — | — | 1.2% | 1.01M | 993.10K |
| Common Stock Indirect | 3/13/2026 | S · Sale | −24.14K | $50.09 | $1.21M | 2.4% | 993.10K | 968.96K |
| Common Stock Indirect | 3/13/2026 | S · Sale | −10.74K | $51.00 | $547.84K | 1.1% | 968.96K | 958.22K |
| Common Stock Indirect | 3/13/2026 | S · Sale | −120.00 | $51.75 | $6.21K | 0.0% | 958.22K | 958.10K |
| Total | −35K | -$1.76M | ||||||
Derivative Transactions0
No derivative transactions reported